Lipoplatin Formulation Review Article

por Stathopoulos, G. P., Boulikas, T.
Publicado 2012

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer

por Stathopoulos, G. P., Antoniou, D., Dimitroulis, J., Stathopoulos, J., Marosis, K., Michalopoulou, P.
Publicado 2011

Combination of three cytotoxic agents in small-cell lung cancer

por Stathopoulos, G. P., Trafalis, D., Dimitroulis, J., Kosmas, Ch., Stathopoulos, J., Tsavdaridis, D.
Publicado 2012

Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.

por Baxevanis, C. N., Dedoussis, G. V., Gritzapis, A. D., Stathopoulos, G. P., Papamichail, M.
Publicado 1994

Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I–II trial

por Stathopoulos, G P, Dimitroulis, J, Antoniou, D, Katis, C, Tsavdaridis, D, Armenaki, O, Marosis, C, Michalopoulou, P, Grigoratou, T, Stathopoulos, J
Publicado 2005

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancrea...

por Stathopoulos, G P, Syrigos, K, Aravantinos, G, Polyzos, A, Papakotoulas, P, Fountzilas, G, Potamianou, A, Ziras, N, Boukovinas, J, Varthalitis, J, Androulakis, N, Kotsakis, A, Samonis, G, Georgoulias, V
Publicado 2006

Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial

por Stathopoulos, G. P., Antoniou, D., Dimitroulis, J., Michalopoulou, P., Bastas, A., Marosis, K., Stathopoulos, J., Provata, A., Yiamboudakis, P., Veldekis, D., Lolis, N., Georgatou, N., Toubis, M., Pappas, Ch., Tsoukalas, G.
Publicado 2010